EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

N‐Terminal Propeptide of Procollagen Type III (PIIINP) as a Biomarker for Liver Fibrosis Severity: A Systematic Review and Meta‐Analysis

Fatemeh Famouri, Hamideh Komeilyfard, Hossein Saneian, Peiman Nasri, Majid Khademian iD, Mohammad Reza Maracy

International Journal of Pediatrics · 2026-01 · 2026 (1)

DOI: 10.1155/ijpe/7410174 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Pediatrics, online erschienen am 15.11.2026. Verfasst von Fatemeh Famouri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics Imam Hossein Children Hospital Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The invasive nature of liver biopsy, the gold standard for liver fibrosis assessment, underscores the critical need for robust noninvasive biomarkers. The N‐terminal propeptide of procollagen Type III (PIIINP), a direct marker of fibrogenesis, is one such candidate. Despite numerous primary studies, there has been no definitive meta‐analysis to quantitatively summarize its diagnostic performance across different fibrosis stages and etiologies. This systematic review and meta‐analysis was therefore conducted to precisely determine the pooled diagnostic accuracy of PIIINP for detecting and staging liver fibrosis and cirrhosis.

Methods

We conducted a comprehensive literature search across PubMed, Scopus, Web of Science, and Embase. Eighteen studies, comprising 4639 individuals, were included for qualitative assessment and meta‐analysis. Study quality was generally high (15 studies), with two rated as fair and one as low. A total of 30 substudies were analyzed from these 18 publications, as several studies reported multiple outcome measures. The primary aim was to evaluate the diagnostic accuracy of PIIINP for detecting and staging liver fibrosis and cirrhosis.

Results

The pooled diagnostic metrics for PIIINP in determining liver fibrosis severity were as follows: sensitivity, 72.29% (95% CI: 64.72–79.87); specificity, 79.34% (95% CI: 74.02–84.66); positive predictive value, 61.70% (95% CI: 49.49–73.90); negative predictive value, 81.29% (95% CI: 73.14–89.43); area under the curve, 0.75 (95% CI: 0.70–0.81); and overall accuracy, 73.29% (95% CI: 70.53–76.05). At a cutoff value of 7.34 ng/mL, PIIINP demonstrated a sensitivity of 67% (95% CI: 59–75) and a specificity of 77% (95% CI: 72–82) for differentiating advanced fibrosis or cirrhosis from milder stages.

Conclusion

PIIINP demonstrates clinically useful accuracy as a noninvasive biomarker for assessing liver fibrosis severity, independent of underlying etiology. Its strong negative predictive value is particularly valuable for ruling out advanced disease. Future research should focus on validating disease‐specific cutoffs and integrating PIIINP into standardized diagnostic algorithms for targeted patient populations.

Schlagwörter

Stichwörter der Autor:innen

N-terminal propeptide of procollagen Type IIIbiopsycollagen Type IIIliver cirrhosisliver fibrosis

Autor:innen und Institutionen

  • Department of Pediatrics Imam Hossein Children Hospital Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir.
  • Metabolic Liver Disease Research Center Imam Hossein Children Hospital Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir.
  • Child Growth and Development Research Center Research Institute for Primordial Prevention of Non-Communicable Disease Imam Hossein Children Hospital Isfahan Iran.
  • Department of Epidemiology & Biostatistics School of Public Health Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir.

ORCID-Profile: Majid Khademian

Zitieren

APA

Famouri, F., Komeilyfard, H., Saneian, H., Nasri, P., Khademian, M., & Maracy, M. R. (2026). N‐Terminal Propeptide of Procollagen Type III (PIIINP) as a Biomarker for Liver Fibrosis Severity: A Systematic Review and Meta‐Analysis. International Journal of Pediatrics, 2026(1). https://doi.org/10.1155/ijpe/7410174

Vancouver

Famouri F, Komeilyfard H, Saneian H, Nasri P, Khademian M, Maracy MR. N‐Terminal Propeptide of Procollagen Type III (PIIINP) as a Biomarker for Liver Fibrosis Severity: A Systematic Review and Meta‐Analysis. International Journal of Pediatrics. 2026;2026(1). doi:10.1155/ijpe/7410174

BibTeX
@article{Famouri2026,
  author = {Famouri, Fatemeh and Komeilyfard, Hamideh and Saneian, Hossein and Nasri, Peiman and Khademian, Majid and Maracy, Mohammad Reza},
  title = {N‐Terminal Propeptide of Procollagen Type III (PIIINP) as a Biomarker for Liver Fibrosis Severity: A Systematic Review and Meta‐Analysis},
  journal = {International Journal of Pediatrics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijpe/7410174}
}
Kostenlos starten →